| pubmed-article:20127904 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20127904 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:20127904 | lifeskim:mentions | umls-concept:C0003440 | lld:lifeskim |
| pubmed-article:20127904 | lifeskim:mentions | umls-concept:C0679823 | lld:lifeskim |
| pubmed-article:20127904 | lifeskim:mentions | umls-concept:C0332282 | lld:lifeskim |
| pubmed-article:20127904 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:20127904 | pubmed:dateCreated | 2010-3-22 | lld:pubmed |
| pubmed-article:20127904 | pubmed:abstractText | Results from the Superior Yield of the New Strategy of Enoxaparin, Revascularization, and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial showed that the low-molecular-weight heparin (LMWH) enoxaparin was non-inferior compared with unfractionated heparin (UFH) in patients with non-ST-elevation acute coronary syndromes (NSTE-ACS) managed invasively. | lld:pubmed |
| pubmed-article:20127904 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20127904 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20127904 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20127904 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20127904 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20127904 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20127904 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20127904 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20127904 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20127904 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20127904 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20127904 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:20127904 | pubmed:issn | 1932-8737 | lld:pubmed |
| pubmed-article:20127904 | pubmed:author | pubmed-author:OhmanE... | lld:pubmed |
| pubmed-article:20127904 | pubmed:author | pubmed-author:ShahBimal RBR | lld:pubmed |
| pubmed-article:20127904 | pubmed:author | pubmed-author:DeLongElizabe... | lld:pubmed |
| pubmed-article:20127904 | pubmed:author | pubmed-author:PetersonEric... | lld:pubmed |
| pubmed-article:20127904 | pubmed:author | pubmed-author:GiblerW... | lld:pubmed |
| pubmed-article:20127904 | pubmed:author | pubmed-author:MahaffeyKenne... | lld:pubmed |
| pubmed-article:20127904 | pubmed:author | pubmed-author:RoeMatthew... | lld:pubmed |
| pubmed-article:20127904 | pubmed:author | pubmed-author:PollackCharle... | lld:pubmed |
| pubmed-article:20127904 | pubmed:author | pubmed-author:ChenAnita YAY | lld:pubmed |
| pubmed-article:20127904 | pubmed:copyrightInfo | Copyright (c) 2009 Wiley Periodicals, Inc. | lld:pubmed |
| pubmed-article:20127904 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20127904 | pubmed:volume | 33 | lld:pubmed |
| pubmed-article:20127904 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20127904 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20127904 | pubmed:pagination | E49-55 | lld:pubmed |
| pubmed-article:20127904 | pubmed:meshHeading | pubmed-meshheading:20127904... | lld:pubmed |
| pubmed-article:20127904 | pubmed:meshHeading | pubmed-meshheading:20127904... | lld:pubmed |
| pubmed-article:20127904 | pubmed:meshHeading | pubmed-meshheading:20127904... | lld:pubmed |
| pubmed-article:20127904 | pubmed:meshHeading | pubmed-meshheading:20127904... | lld:pubmed |
| pubmed-article:20127904 | pubmed:meshHeading | pubmed-meshheading:20127904... | lld:pubmed |
| pubmed-article:20127904 | pubmed:meshHeading | pubmed-meshheading:20127904... | lld:pubmed |
| pubmed-article:20127904 | pubmed:meshHeading | pubmed-meshheading:20127904... | lld:pubmed |
| pubmed-article:20127904 | pubmed:meshHeading | pubmed-meshheading:20127904... | lld:pubmed |
| pubmed-article:20127904 | pubmed:meshHeading | pubmed-meshheading:20127904... | lld:pubmed |
| pubmed-article:20127904 | pubmed:meshHeading | pubmed-meshheading:20127904... | lld:pubmed |
| pubmed-article:20127904 | pubmed:meshHeading | pubmed-meshheading:20127904... | lld:pubmed |
| pubmed-article:20127904 | pubmed:meshHeading | pubmed-meshheading:20127904... | lld:pubmed |
| pubmed-article:20127904 | pubmed:meshHeading | pubmed-meshheading:20127904... | lld:pubmed |
| pubmed-article:20127904 | pubmed:meshHeading | pubmed-meshheading:20127904... | lld:pubmed |
| pubmed-article:20127904 | pubmed:meshHeading | pubmed-meshheading:20127904... | lld:pubmed |
| pubmed-article:20127904 | pubmed:meshHeading | pubmed-meshheading:20127904... | lld:pubmed |
| pubmed-article:20127904 | pubmed:meshHeading | pubmed-meshheading:20127904... | lld:pubmed |
| pubmed-article:20127904 | pubmed:meshHeading | pubmed-meshheading:20127904... | lld:pubmed |
| pubmed-article:20127904 | pubmed:meshHeading | pubmed-meshheading:20127904... | lld:pubmed |
| pubmed-article:20127904 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20127904 | pubmed:articleTitle | Influence of clinical trial participation on subsequent antithrombin use. | lld:pubmed |
| pubmed-article:20127904 | pubmed:affiliation | Duke Clinical Research Institute, Duke University Medical Center, 2400 Pratt Street, Durham, NC 27705, USA. bimal.shah@duke.edu | lld:pubmed |
| pubmed-article:20127904 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20127904 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:20127904 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
